Oral ulcerDisease1 paperMeSH D019226Human trial1Trial sponsorsDow University of Health Sciences1 trialEarly phase 175 peopleLatestLancet·14 NovEfficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialRandomised trial in 117 peoplemTOR inhibitorsPaper
Lancet·14 NovEfficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialRandomised trial in 117 peoplemTOR inhibitorsPaper